US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms

A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval. Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […]

The post US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms appeared first on Good News Network.